A single chemotherapy drugs: the current clinical application of a single chemotherapy drugs are rare. This method mainly used for chemotherapy early or preventive chemotherapy. For cervical cancer more effective drugs cyclophosphamide, 5-fluorouracil, bleomycin and mitomycin C, doxorubicin, methotrexate, cisplatin, the hospitals reported mixed effect, the response rates in the 6% to 25%. In various chemotherapy drugs, cisplatin in the treatment of cervical cancer is the most widely and more effective drugs, it has chemotherapy drugs and radiation sensitizer the dual role of cervical cancer remission rate of about 25%. The joint use of chemotherapy drugs can improve remission rate, such as a single application of the remission rate cisplatin is less than 30%, and when combined up to 60%. In recent years, Thailand has been the application of concern, such as the application of Thai and foreign experts in the treatment of 32 patients with advanced cervical cancer recurrence and, with a total response rate of 25%.

     Joint drug chemotherapy: current advanced cancer or recurrent cancer with surgery, radiotherapy and use, the use of combined chemotherapy drugs, a single chemotherapy drugs have a better effect. In combination, we should be mindful five principles. First, the combination of drugs in a single medication to be effective; The second is to use different mechanisms of anti-tumor drugs; Third, no cumulative toxicity; Fourth, the dose of each drug may be used to be close to the effective dose; 5, the combination of drugs can not be reduced between Validity and antagonistic role. At present, the application of joint drug chemotherapy in the treatment of cervical cancer is efficient, the hospitals reported results for the other, efficiency from 32% to 89% range.